# Phase II Study of First-line SBRT in Patients With Non-Metastatic Unresectable Pancreatic Cancer

> **NCT01434550** · NA · WITHDRAWN · sponsor: **H. Lee Moffitt Cancer Center and Research Institute**

## Conditions studied

- Pancreatic Tumor

## Interventions

- **RADIATION:** Stereotactic Body Radiation Therapy (SBRT)
- **RADIATION:** Tissue, Blood, Research Imaging (TBRI)

## Key facts

- **NCT ID:** NCT01434550
- **Lead sponsor:** H. Lee Moffitt Cancer Center and Research Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-03
- **Primary completion:** 2015-08
- **Final completion:** 2015-08
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** research cancelled
- **Last updated:** 2017-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01434550

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01434550, "Phase II Study of First-line SBRT in Patients With Non-Metastatic Unresectable Pancreatic Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01434550. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*